Landscapes / Targets
CaSR
4 drugs act on CaSR, in 8 active trials · Any stage · updated 19 Nov 2026
FollowEvery change as it happens, and a Monday email
Drugs4
| Drug | How it works | Company | Stage
Sources: FDA: the drug development process, ClinicalTrials.gov glossary | Next date
| Details |
|---|---|---|---|---|---|
Calcium-sensing receptor agonist |
Amgen · Public AMGN |
Approved | 30 Jun 2027Phase 3 trial completes | ||
| Next date | 30 Jun 2027 · Phase 3 trial completes | ||||
| Also tested for | Secondary Hyperparathyroidism, Chronic Kidney Disease | ||||
| Open drug page | |||||
— |
Approved in Japan | 22 Feb 2032Phase 3 trial completes | |||
| Next date | 22 Feb 2032 · Phase 3 trial completes | ||||
| Also tested for | Chronic Kidney Disease (CKD), Secondary Hyperparathyroidism | ||||
| Open drug page | |||||
— |
Phase 3 | 26 Nov 2026soonPhase 3 trial completes | |||
| Next date | 26 Nov 2026 · Phase 3 trial completes | ||||
| Also tested for | Secondary Hyperparathyroidism (SHPT) in Subjects With Chronic Kidney Disease (CKD) on Hemodialysis, Secondary Hyperparathyroidism, Chronic Kidney Disease | ||||
| Open drug page | |||||
— |
Phase 3 | Jan 2028Phase 3 trial completes | |||
| Next date | Jan 2028 · Phase 3 trial completes | ||||
| Also tested for | Autosomal Dominant Hypocalcemia (ADH), Autosomal Dominant Hypocalcemia Type 1 (ADH1) and 2 more | ||||
| Open drug page | |||||
No drugs match “”.
About this list
- Checked
- 4 of 4 drugs. How we check
- Matches
- The mechanism of checked drugs, and drug names, so a drug not checked yet may be missing.
- Sources
- ClinicalTrials.gov updated 19 Nov 2026 · openFDA updated 19 Nov 2026